Triple-negative breast cancer lacks the expression of estrogen and progesterone receptors, and human epithelial growth factor 2 receptors (HER2; also known as ErbB2), and shares characteristics with basal-like, claudin-low, and BRCA1-related breast cancer. Here, ERBB2 is linked to breast cancer.